Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection
Clinical trial NCT02021643 · COMPLETED
Trial details
- NCT number
- NCT02021643
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-10
- Primary completion
- 2016-08-12
- Enrollment
- 687
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.